Stephen Willie
Analyst
Stifel
Equibles does not estimate personal net worth.
About Stephen Willie
Stephen Willie is recorded as Analyst at Stifel. Stephen Willie has spoken on 2 investor events across 1 company, most recently for Candel Therapeutics, Inc. on November 10, 2026. The companies whose calls Stephen Willie spoke on are classified in the Healthcare sector.
Stephen Willie on recent calls
“So let's jump into aglatimogene for localized prostate cancer. Maybe we can just start off with the PRTK05 data you just presented at CITSI. I know the mechanism of this drug is pretty unique.”
“So let's jump into aglatimogene for localized prostate cancer. Maybe we can just start off with the PRTK05 data you just presented at CITSI. I know the mechanism of this drug is pretty unique.”
Affiliation history
-
Stifel
Analyst
Transcript header (unverified)
Current